Rosetta receives NOA for U.S. patent app

The USPTO issues a Notice of Allowance for Rosetta Genomics' (ROSG +0.8%) patent application 13/977,797 entitled "Compositions and Methods for Treatment of Ovarian Cancer." The patent relates to the inhibition of miR-210 for the treatment of ovarian cancer.

The patent, when issued, will be the company's 33rd in the U.S. It has 27 patent applications pending.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs